“Treating Ulcerative Colitis in the Acute Care Setting”
Event Navigation
HealthTrust presents…“Treating Ulcerative Colitis in the Acute Care Setting”
Pharmacotherapy for the acute management of refractory ulcerative colitis flares is limited. High doses of steroids and immunosuppressants are the mainstay of therapy. In many refractory cases, surgical resection and ostomy formation are the only options.Current ulcerative colitis guidelines published in 2020 focus mainly on the outpatient management. The recommended medications used for inpatient management of acute ulcerative colitis flares have not changed; however, recent studies have investigated new dosing strategies and acute phase application of maintenance therapies. This session will review the current guidelines and challenges for acute management of refractory ulcerative colitis, including a discussion of the literature behind applying novel therapy plans and dosing strategies. The advantages of these novel strategies, such as ease of transition to outpatient regimens will be discussed in addition to their challenges, such as cost.
Learning Objectives for Pharmacists & Nurses | At the end of this session, participants should be able to:
- Recall the current guidelines for acute management of ulcerative colitis and transition to maintenance therapies.
- Recognize treatment plans based on stage of ulcerative colitis and patient-specific factors to optimize safe and effective acute management of ulcerative colitis.
- Identify advantages and challenges of newer pharmacotherapy options for acute management of ulcerative colitis including small molecules, monoclonal antibodies, and novel pipeline agents.
Learning Objectives for Pharmacy Techs | At the end of this session, participants should be able to:
- Recall medications used in the treatment of ulcerative colitis that are classified as NIOSH hazardous drugs.
- Identify medications that can worsen ulcerative colitis.
- Recognize the appropriate dose for weight-based medication regimens for acute management of ulcerative colitis.
Presenter:
Clare Newell, PharmD. PGY-1 Pharmacy Resident | Atlantic HealthSystem
Target Audience: Pharmacists, Pharmacy Techs & Nurses
CE Credit: Approved for Pharmacists, Pharmacy Techs & Nurses
This program is approved for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Numbers for this activity are 0863-9999-24-054-L01-P and 0863-9999-24-054-L01-T. The activity is approved for 1 hour (.1 CEUs) of continuing education credit for Pharmacists, Pharmacy Techs & Nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.
Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
